Posters presented at the XVII SDDN Meeting - A Coruña 2025.
Send us yours too !

Poster CodePresenterInstitutionTitlePDF
P01Raquel Maria González SoengasUniversidad de OviedoLiposomal Formulations of Gold(III) Complexes against Multidrug Resistant Staphyloccocus spp. strainsP01 Raquel Maria González Soengas
P02Núria Valls VidalALBA SynchrotronALBA Synchrotron: A Cutting-Edge Resource for Pharmaceutical CompaniesP02 Núria Valls Vidal
P03Rosa MongeBeonchip S.L.Advancing Preclinical Models with Beonchip Organ-on-Chip TechnologyP03 Rosa Monge
P04Concepción González BelloCentro Singular de Investigación en Química Biolóxica e Materiais Moleculares (CIQUS), Universidade de Santiago de Compostela (USC)Penicillin-based sulfone-siderophore conjugates for restoring beta-lactam antibiotic eddicacy in multidrug-resistant bacteriaP04 Concepción González Bello
P05Marc TerronesBeCYTES Biotechnologies SL.Integration of liver tumor organoids and in silico methods to address drug resistance (LIVERtera)P05 Marc Terrones
P06Santiago VázquezUniversitat de BarcelonaEDDU: Early Drug Discovery UnitP06 Santiago Vázquez
P07Esther Masiá SanchisCentro de Investigación Príncipe FelipeA novel pro-apoptotic-based combination therapy for pediatric solid tumor treatmentP07 Esther Masiá
P08Manuel Novás GonzálezUniversidad de Santiago de CompostelaNovel Benzothiazole derivates for the treatment of neurodegenerative disorders: study in phenotypic alzheimer's disease modelP08 Manuel Novás
P09Elisa Marín-JerezVivoArchitectReducing heat-stress mortality in poultry by oral supplementsP09 Elisa Marín
P10Elisa Marín-JerezVivoArchitectPreventing hypothermia through oral supplementation in mice P10 Elisa Marín
P11Óscar Díaz SanzoNanomaterials and Nanotechnology Research Center (CINN-CSIC)Structural Insights on adenosine A2A / A2B dual antagonism by free energy perturbation P11 Óscar Díaz
P12Laia Josa-CulleréInstitute for Advanced Chemistry of Catalonia (IQAC-CSIC)Photocaged chloroquine derivatives for the light-dependent inhibition of autophagy in cancer stem cells P12 Laia Josa
P13Lara González-RendoCentro Singular de Investigación en Medicina Molecular e Enfermidades Crónicas (CIMUS - USC)Validation of an antitumor compound in 2D and 3D gliobastoma models P13 Lara González
P14Leslye Paola Valarezo RiascosCentro Singular de Investigación en Medicina Molecular e Enfermidades Crónicas (CIMUS - USC)Study and Identification of G Protein-Coupled Receptor Interactions in an In Vitro Phenotypic Model of Schizophrenia: Effects of Antipsychotic Drugs P14 Leslye Paola Valarezo
P15Irantzu Pérez-RuizScantox Neuro GmbHDiverse approaches to 3D neural models: insights into organoid and spheroid systems for neurodegenerative disease research P15 Irantzu Pérez-Ruiz
P16Juan Abeigón MoureCentro Singular de Investigación en Medicina Molecular e Enfermidades Crónicas (CIMUS - USC)Development of a miniaturized phenotypic assay for drug screening in polycystic kidney disease P16 Juan Abeigón
P17Andrea Balsa-DíazBflow S.L.Microfluidic chip for advanced blood-brain barrier co-culture P17 Andrea Balsa-Díaz
P18Ana Rodríguez PedrouzoCentro Interdisciplinar de Química e Bioloxía (CICA-UDC)Protease-Activated Trojan Horses: A New Route to Defeat Acinetobacter
baumannii
P18 Ana Rodríguez
P19Mariña Durán-RubíCentro Singular de Investigación en Medicina Molecular e Enfermidades Crónicas (CIMUS - USC)Differential activation of the JAK/STAT pathway in ulcerative colitis: analysis
of the inflammatory response and sex-based variability
P19 Mariña Durán
P20Brahimi Mohamed HabibUniversidad de Santiago de Compostela4-aryl-1,2-dithiole-3-thiones: synthesis, antimicrobial activity, and molecular docking insights P20 Mohamed Habib
P21Marta Martínez-GarcíaFundación MEDINAReversing chemotherapy resistance in triple-negative breast cancer with natural compounds P21 Marta Martínez
P22Alberto Pitarch SanzCentro de Investigación Príncipe Felipe (CIPF)Optimized 3D phenotypic assays for high-content and high-throughput screening in drug discovery P22 Alberto Pitarch
P23Stefano BenvegnuARUK UCL Drug Discovery Institute, London UKRestoring Wnt signalling in the brain vasculature through inhibition of Notum enzyme: a Lead to Preclinical Candidate for Alzheimer’s disease. P23 Stefano Benvegnu
P24Elena CuberoGain Therapeutics Targeting Allosteric Sites in Drug Discovery P24 Elena Cubero
P25Xavier Rovira & Carme SerraMCS, Institut for Advanced Chemistry of Catalonia – CSICPhotopharmacology repurposing old GPCR targets with new smart drugs P25 Xavier Rovira & Carme Serra
P26Raquel LamaCentro Singular de Investigación en Medicina Molecular e Enfermidades Crónicas (CIMUS - USC)Development of a 3D pharmacological SH-SY5Y neurosphere model to study pathological mechanisms underlying cognitive impairment and its application in drug discovery P26 Raquel Lama
P27Toni GómezPredictive AI & Data,Clinical Pharmacology Safety Sciences, AstraZenecaAdvancing Toxicity Prediction Through Autoencoder Analysis of High-Throughput Transcriptomics Data P27 Toni Gómez
P28Shivaprasad PatilPredictive AI & Data, AstraZenecaUnlocking Biological Insights Through AI-driven Multi-Omics Integration. P28 Shivaprasad Patil
P29María R. González-BermúdezInstituto de Biología Molecular y Celular de Plantas (IBMCP-UPV-CSIC)Identification of new targets for improving abiotic stress tolerance in plants P29 María R. González
P30Carla Donderis-FagoagaInstituto de Biología Molecular y Celular de Plantas (IBMCP-UPV-CSIC)Pioneering Plant PROTACs: Expanding the Agrochemical Toolbox P30 Carla Donderis
P31Jorge Lozano-JusteInstituto de Química-Física "Blas Cabrera" (IQF) Consejo Superior de Investigaciones CientíficasMedicinal Chemistry and Plant Biology: Optimizing ABA-receptor Agonists for Drought Tolerance in Crops P31 Jorge Lozano
P32Rafa Ruiz-PartidaInstituto de Biología Molecular y Celular de Plantas (IBMCP-UPV-CSIC)Using Artificial Intelligence to Improve Drought Resistance in Crop Plants P32 Rafa Ruiz
P33Ismael BermejoUniversity of Santiago de CompostelaGiving Synthesized Compounds a New Purpose: Public Spanish Chemical Library P33 Geert Daudey
P34Raquel GarcíaPromega CorporationDevelopment of novel luminescent assays for sensitive and specific
quantitation of double-stranded RNA in mRNA vaccines
P34 Raquel García
P35Xabier CalleVicomtech FoundationTask-Specific Refinement of a Multitask AI Model for Blood–Brain Barrier Prediction P35 Xabier Calle
P36Raquel GarcíaPromega CorporationTextoAutomation-Enabled Target Engagement Selectivity Screening of Small Molecule Kinase Inhibitors P36 Raquel García

Coorganizadores

Socios Protectores de la SDDN

Patrocinadores del XII Meeting de la SDDN